Showing results (21-30 of 552) with videos related to
Sort By:
Pageof 56
Neuropharmacology|July 1, 1995
Therapeutic brain concentration of the NMDA receptor antagonist amantadineJ Kornhuber, G Quack, W Danysz, et al.Journal of Neural Transmission|January 1, 1985
Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm studyW Birkmayer, J Knoll, P Riederer, et al.Wiener Medizinische Wochenschrift. Supplement|January 1, 1979
[Acute pharmacotoxic psychoses in patients with chronic cerebral disorders]W DanielczykJournal of Neural Transmission|January 1, 1983
Various mental behavioral disorders in Parkinson's disease, primary degenerative senile dementia, and multiple infarction dementiaW DanielczykJournal of Neural Transmission. Supplementum|January 1, 1995
Twenty-five years of amantadine therapy in Parkinson's diseaseW DanielczykWiener Klinische Wochenschrift|May 26, 1978
[The EEG in multiple sclerosis (author's transl)]W DanielczykDementia and Geriatric Cognitive Disorders|April 3, 1998
Platelet monoamine oxidase B activity in dementia. A 4-year follow-upM E Götz, P Fischer, W Gsell, et al.Advances in Neurology|January 1, 1987
Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of L-deprenylP Riederer, C Konradi, V Schay, et al.Wiener Klinische Wochenschrift|August 7, 1981
[Treatment of pharmacotoxic psychoses with clopenthixol in patients with Parkinson's disease (author's transl)]W DanielczykWiener Medizinische Wochenschrift (1946)|February 28, 1986
[The aging human from the neuropsychiatric viewpoint]W DanielczykPageof 56